Nadira Dharshani Karunaweera, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leishmaniasis, Cutaneous | 24 | 2024 | 137 | 12.570 |
Why?
|
Leishmania donovani | 19 | 2024 | 68 | 8.070 |
Why?
|
Leishmaniasis, Visceral | 12 | 2024 | 100 | 6.280 |
Why?
|
Sri Lanka | 39 | 2024 | 93 | 4.620 |
Why?
|
Phlebotomus | 6 | 2024 | 12 | 4.270 |
Why?
|
Psychodidae | 5 | 2024 | 27 | 4.250 |
Why?
|
Malaria, Vivax | 12 | 2020 | 166 | 3.390 |
Why?
|
Leishmaniasis | 6 | 2024 | 67 | 2.960 |
Why?
|
Insect Vectors | 6 | 2024 | 136 | 2.650 |
Why?
|
Plasmodium vivax | 14 | 2020 | 202 | 2.430 |
Why?
|
Antimony Sodium Gluconate | 5 | 2023 | 10 | 2.070 |
Why?
|
Antibodies, Protozoan | 6 | 2019 | 251 | 1.970 |
Why?
|
Antiprotozoal Agents | 4 | 2023 | 95 | 1.810 |
Why?
|
Malaria | 7 | 2017 | 1241 | 1.200 |
Why?
|
Climate | 2 | 2024 | 146 | 1.060 |
Why?
|
Malaria, Falciparum | 5 | 2018 | 1075 | 1.060 |
Why?
|
Leishmania | 2 | 2023 | 75 | 1.060 |
Why?
|
Insecticides | 2 | 2020 | 199 | 1.040 |
Why?
|
Antigens, Protozoan | 4 | 2023 | 315 | 1.020 |
Why?
|
Antimalarials | 5 | 2017 | 908 | 1.010 |
Why?
|
Hyperthermia, Induced | 2 | 2021 | 416 | 1.000 |
Why?
|
Leishmania tropica | 1 | 2024 | 8 | 0.960 |
Why?
|
Protozoan Proteins | 3 | 2019 | 844 | 0.770 |
Why?
|
DNA Barcoding, Taxonomic | 2 | 2020 | 134 | 0.760 |
Why?
|
Topography, Medical | 1 | 2021 | 37 | 0.750 |
Why?
|
DNA, Ribosomal | 1 | 2021 | 300 | 0.700 |
Why?
|
Seasons | 2 | 2024 | 1523 | 0.700 |
Why?
|
Merozoite Surface Protein 1 | 1 | 2018 | 36 | 0.630 |
Why?
|
Immunity, Humoral | 2 | 2020 | 610 | 0.590 |
Why?
|
Neglected Diseases | 1 | 2018 | 67 | 0.580 |
Why?
|
Plasmodium ovale | 1 | 2017 | 13 | 0.570 |
Why?
|
Histocytochemistry | 1 | 2018 | 699 | 0.540 |
Why?
|
Microsatellite Repeats | 6 | 2015 | 785 | 0.540 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2017 | 94 | 0.540 |
Why?
|
Polymorphism, Genetic | 4 | 2018 | 4251 | 0.530 |
Why?
|
Chloroquine | 2 | 2017 | 275 | 0.470 |
Why?
|
Bhutan | 2 | 2024 | 61 | 0.460 |
Why?
|
Malaria Vaccines | 1 | 2015 | 164 | 0.440 |
Why?
|
Genetic Variation | 7 | 2021 | 6610 | 0.420 |
Why?
|
Skin | 4 | 2020 | 4507 | 0.410 |
Why?
|
Plasmodium falciparum | 5 | 2018 | 1741 | 0.410 |
Why?
|
Genome | 1 | 2018 | 1752 | 0.350 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1761 | 0.340 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 3814 | 0.320 |
Why?
|
Military Personnel | 1 | 2018 | 1264 | 0.320 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2020 | 16051 | 0.310 |
Why?
|
Phylogeny | 3 | 2024 | 2843 | 0.310 |
Why?
|
Seroepidemiologic Studies | 3 | 2020 | 405 | 0.300 |
Why?
|
Young Adult | 16 | 2024 | 60110 | 0.290 |
Why?
|
Humans | 56 | 2024 | 768887 | 0.290 |
Why?
|
Communicable Disease Control | 1 | 2014 | 857 | 0.280 |
Why?
|
Filaricides | 1 | 2006 | 10 | 0.280 |
Why?
|
Filariasis | 1 | 2006 | 26 | 0.280 |
Why?
|
Drug Discovery | 1 | 2015 | 1068 | 0.280 |
Why?
|
Animals | 21 | 2024 | 169408 | 0.270 |
Why?
|
Linkage Disequilibrium | 8 | 2015 | 1998 | 0.270 |
Why?
|
Cattle | 2 | 2024 | 3820 | 0.270 |
Why?
|
Drug Resistance | 3 | 2023 | 1600 | 0.260 |
Why?
|
Adolescent | 17 | 2024 | 89247 | 0.260 |
Why?
|
Membrane Transport Proteins | 1 | 2011 | 1039 | 0.260 |
Why?
|
Immunoglobulin G | 1 | 2018 | 4568 | 0.250 |
Why?
|
Travel | 2 | 2017 | 805 | 0.250 |
Why?
|
Quinine | 1 | 2005 | 51 | 0.250 |
Why?
|
DNA, Protozoan | 4 | 2019 | 227 | 0.240 |
Why?
|
Treatment Failure | 2 | 2021 | 2663 | 0.240 |
Why?
|
Interleukin-10 | 2 | 2023 | 1184 | 0.230 |
Why?
|
Biopsy | 3 | 2023 | 6805 | 0.230 |
Why?
|
Population Density | 1 | 2024 | 193 | 0.230 |
Why?
|
Haplotypes | 6 | 2017 | 2725 | 0.230 |
Why?
|
Telemedicine | 1 | 2021 | 3109 | 0.230 |
Why?
|
Child, Preschool | 10 | 2024 | 42684 | 0.220 |
Why?
|
Adult | 21 | 2024 | 223818 | 0.220 |
Why?
|
Infant | 8 | 2024 | 36541 | 0.220 |
Why?
|
Genome, Protozoan | 1 | 2024 | 153 | 0.220 |
Why?
|
Hybridization, Genetic | 1 | 2023 | 102 | 0.220 |
Why?
|
Child | 14 | 2024 | 80969 | 0.210 |
Why?
|
Disease Vectors | 1 | 2022 | 61 | 0.210 |
Why?
|
Middle Aged | 19 | 2024 | 223740 | 0.210 |
Why?
|
Male | 26 | 2024 | 365249 | 0.210 |
Why?
|
Genomics | 2 | 2016 | 5928 | 0.200 |
Why?
|
Female | 26 | 2024 | 397464 | 0.200 |
Why?
|
Membrane Proteins | 1 | 2018 | 7885 | 0.190 |
Why?
|
Unfolded Protein Response | 1 | 2023 | 239 | 0.190 |
Why?
|
Knowledge | 1 | 2022 | 178 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2023 | 4356 | 0.180 |
Why?
|
Disease Notification | 1 | 2021 | 95 | 0.180 |
Why?
|
Nepal | 2 | 2019 | 301 | 0.180 |
Why?
|
Insecticide Resistance | 1 | 2020 | 22 | 0.180 |
Why?
|
Skin Ulcer | 1 | 2021 | 130 | 0.180 |
Why?
|
Pyrethrins | 1 | 2020 | 46 | 0.170 |
Why?
|
Acetylcholinesterase | 1 | 2020 | 151 | 0.170 |
Why?
|
Injections, Intralesional | 1 | 2021 | 280 | 0.170 |
Why?
|
Leukocytes | 1 | 2007 | 2034 | 0.160 |
Why?
|
Mixed Function Oxygenases | 1 | 2020 | 265 | 0.160 |
Why?
|
Aged | 12 | 2024 | 171790 | 0.160 |
Why?
|
Photography | 1 | 2021 | 537 | 0.150 |
Why?
|
Principal Component Analysis | 1 | 2021 | 948 | 0.150 |
Why?
|
DNA, Kinetoplast | 1 | 2017 | 12 | 0.150 |
Why?
|
Bone Marrow | 2 | 2019 | 2935 | 0.150 |
Why?
|
Glutathione Transferase | 1 | 2020 | 564 | 0.150 |
Why?
|
Temperature | 1 | 2024 | 2235 | 0.150 |
Why?
|
INDEL Mutation | 1 | 2018 | 267 | 0.150 |
Why?
|
Primaquine | 1 | 2017 | 28 | 0.140 |
Why?
|
Endoplasmic Reticulum | 1 | 2023 | 1133 | 0.140 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7860 | 0.140 |
Why?
|
Serologic Tests | 1 | 2019 | 383 | 0.140 |
Why?
|
Case-Control Studies | 5 | 2024 | 22294 | 0.140 |
Why?
|
Liberia | 1 | 2017 | 176 | 0.140 |
Why?
|
Quality of Life | 1 | 2018 | 13510 | 0.140 |
Why?
|
Parasitemia | 1 | 2017 | 165 | 0.130 |
Why?
|
Cluster Analysis | 3 | 2019 | 2730 | 0.130 |
Why?
|
Microscopy | 2 | 2020 | 909 | 0.130 |
Why?
|
Patient Compliance | 1 | 2006 | 2701 | 0.130 |
Why?
|
Lipids | 1 | 2007 | 3345 | 0.130 |
Why?
|
HLA-A Antigens | 1 | 2016 | 223 | 0.130 |
Why?
|
Bangladesh | 1 | 2018 | 741 | 0.130 |
Why?
|
Anemia, Hemolytic | 1 | 2017 | 164 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1855 | 0.130 |
Why?
|
Chromosomes | 1 | 2018 | 578 | 0.130 |
Why?
|
Open Reading Frames | 1 | 2018 | 818 | 0.120 |
Why?
|
Fever | 2 | 2017 | 1620 | 0.120 |
Why?
|
Aneuploidy | 1 | 2018 | 573 | 0.120 |
Why?
|
HLA-B Antigens | 1 | 2016 | 328 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2004 | 0.120 |
Why?
|
Virulence | 1 | 2018 | 1298 | 0.120 |
Why?
|
India | 2 | 2019 | 2325 | 0.120 |
Why?
|
Genotype | 4 | 2017 | 13048 | 0.120 |
Why?
|
Family Characteristics | 1 | 2019 | 1002 | 0.120 |
Why?
|
Sex Factors | 2 | 2020 | 10641 | 0.120 |
Why?
|
Incidence | 3 | 2021 | 21545 | 0.110 |
Why?
|
Mosquito Control | 1 | 2015 | 110 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 984 | 0.110 |
Why?
|
Polymerase Chain Reaction | 3 | 2019 | 6085 | 0.110 |
Why?
|
Gene Dosage | 1 | 2018 | 1222 | 0.110 |
Why?
|
Aged, 80 and over | 7 | 2019 | 59738 | 0.110 |
Why?
|
Antigens, Helminth | 1 | 2014 | 69 | 0.110 |
Why?
|
Elephantiasis, Filarial | 1 | 2014 | 31 | 0.110 |
Why?
|
Homozygote | 1 | 2018 | 1779 | 0.110 |
Why?
|
Hemoglobin, Sickle | 2 | 2015 | 113 | 0.110 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2015 | 209 | 0.110 |
Why?
|
Helminthiasis | 1 | 2014 | 81 | 0.110 |
Why?
|
Interferon-gamma | 2 | 2017 | 3163 | 0.110 |
Why?
|
Base Sequence | 3 | 2019 | 12430 | 0.110 |
Why?
|
Interleukin-4 | 1 | 2017 | 1157 | 0.100 |
Why?
|
Host-Parasite Interactions | 1 | 2015 | 303 | 0.100 |
Why?
|
Genetic Markers | 2 | 2016 | 2604 | 0.100 |
Why?
|
Anopheles | 1 | 2015 | 193 | 0.100 |
Why?
|
Inflammation | 2 | 2023 | 10869 | 0.100 |
Why?
|
Sex Distribution | 2 | 2009 | 2280 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 620 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1157 | 0.100 |
Why?
|
Prevalence | 3 | 2020 | 15875 | 0.100 |
Why?
|
Th1 Cells | 1 | 2017 | 1042 | 0.100 |
Why?
|
Cytokines | 2 | 2023 | 7453 | 0.100 |
Why?
|
Heterozygote | 1 | 2018 | 2798 | 0.100 |
Why?
|
Social Stigma | 1 | 2018 | 788 | 0.100 |
Why?
|
Age Distribution | 2 | 2009 | 2875 | 0.100 |
Why?
|
Th2 Cells | 1 | 2017 | 1079 | 0.090 |
Why?
|
Cross-Sectional Studies | 5 | 2019 | 26384 | 0.090 |
Why?
|
Biological Evolution | 1 | 2016 | 1078 | 0.090 |
Why?
|
School Health Services | 1 | 2014 | 388 | 0.090 |
Why?
|
Rural Population | 2 | 2019 | 2322 | 0.090 |
Why?
|
Goals | 1 | 2015 | 716 | 0.080 |
Why?
|
Down-Regulation | 1 | 2017 | 2941 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3562 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14795 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2018 | 4053 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7245 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3411 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4784 | 0.080 |
Why?
|
Up-Regulation | 1 | 2017 | 4148 | 0.070 |
Why?
|
History, 21st Century | 1 | 2014 | 1575 | 0.070 |
Why?
|
Phenotype | 2 | 2023 | 16735 | 0.070 |
Why?
|
Cell Aggregation | 1 | 2007 | 238 | 0.070 |
Why?
|
Vitamin A Deficiency | 1 | 2007 | 88 | 0.070 |
Why?
|
History, 20th Century | 1 | 2014 | 2771 | 0.060 |
Why?
|
Risk Factors | 2 | 2024 | 74971 | 0.060 |
Why?
|
Absenteeism | 1 | 2007 | 247 | 0.060 |
Why?
|
Rural Health | 1 | 2006 | 300 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9621 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18454 | 0.060 |
Why?
|
Government Programs | 1 | 2006 | 278 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9384 | 0.060 |
Why?
|
Urban Health | 1 | 2006 | 535 | 0.060 |
Why?
|
Antimony | 1 | 2023 | 20 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2020 | 26394 | 0.060 |
Why?
|
Vitamin A | 1 | 2007 | 611 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5544 | 0.050 |
Why?
|
Asia | 2 | 2015 | 629 | 0.050 |
Why?
|
Population Surveillance | 1 | 2014 | 2597 | 0.050 |
Why?
|
Piper betle | 1 | 2002 | 1 | 0.050 |
Why?
|
Cassia | 1 | 2002 | 3 | 0.050 |
Why?
|
Turpentine | 1 | 2002 | 10 | 0.050 |
Why?
|
Ethiopia | 2 | 2019 | 483 | 0.050 |
Why?
|
Mineral Oil | 1 | 2002 | 21 | 0.050 |
Why?
|
Toxins, Biological | 1 | 2003 | 59 | 0.050 |
Why?
|
Myiasis | 1 | 2002 | 14 | 0.050 |
Why?
|
Oils, Volatile | 1 | 2002 | 14 | 0.050 |
Why?
|
Irritants | 1 | 2002 | 43 | 0.050 |
Why?
|
Time Factors | 4 | 2014 | 40266 | 0.050 |
Why?
|
Emollients | 1 | 2002 | 42 | 0.050 |
Why?
|
Africa | 2 | 2015 | 726 | 0.050 |
Why?
|
Diptera | 1 | 2002 | 50 | 0.050 |
Why?
|
Hydrocarbons | 1 | 2002 | 105 | 0.050 |
Why?
|
Epidemiologic Methods | 1 | 2006 | 1328 | 0.050 |
Why?
|
Community Health Services | 1 | 2006 | 659 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 14199 | 0.050 |
Why?
|
Larva | 1 | 2002 | 514 | 0.050 |
Why?
|
Phytotherapy | 1 | 2002 | 298 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2010 | 12798 | 0.040 |
Why?
|
Brazil | 2 | 2019 | 1249 | 0.040 |
Why?
|
Lymphokines | 1 | 2003 | 927 | 0.040 |
Why?
|
Disease Transmission, Infectious | 1 | 2005 | 560 | 0.040 |
Why?
|
Snake Bites | 1 | 2019 | 29 | 0.040 |
Why?
|
Patents as Topic | 1 | 2020 | 111 | 0.040 |
Why?
|
Plant Extracts | 1 | 2002 | 499 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4862 | 0.040 |
Why?
|
Genetics, Population | 2 | 2015 | 944 | 0.040 |
Why?
|
Spain | 1 | 2019 | 485 | 0.040 |
Why?
|
Unemployment | 1 | 2019 | 211 | 0.040 |
Why?
|
Americas | 1 | 2015 | 110 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30266 | 0.030 |
Why?
|
Madagascar | 1 | 2015 | 111 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 65485 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2019 | 2179 | 0.030 |
Why?
|
DNA Primers | 1 | 2019 | 2827 | 0.030 |
Why?
|
South America | 1 | 2015 | 180 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14751 | 0.030 |
Why?
|
Alleles | 2 | 2016 | 6901 | 0.030 |
Why?
|
Necatoriasis | 1 | 2014 | 1 | 0.030 |
Why?
|
Necator americanus | 1 | 2014 | 1 | 0.030 |
Why?
|
Wuchereria bancrofti | 1 | 2014 | 20 | 0.030 |
Why?
|
Ascariasis | 1 | 2014 | 13 | 0.030 |
Why?
|
Ascaris lumbricoides | 1 | 2014 | 10 | 0.030 |
Why?
|
Parasite Egg Count | 1 | 2014 | 29 | 0.030 |
Why?
|
Trichuriasis | 1 | 2014 | 24 | 0.030 |
Why?
|
Trichuris | 1 | 2014 | 32 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 2015 | 4624 | 0.030 |
Why?
|
Health Status | 1 | 2007 | 4095 | 0.030 |
Why?
|
Soil | 1 | 2014 | 120 | 0.030 |
Why?
|
Geography | 1 | 2015 | 654 | 0.030 |
Why?
|
Africa South of the Sahara | 1 | 2015 | 752 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2009 | 15955 | 0.020 |
Why?
|
Survival Rate | 1 | 2005 | 12873 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7602 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2020 | 81892 | 0.020 |
Why?
|
Myanmar | 1 | 2010 | 43 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3913 | 0.020 |
Why?
|
Gambia | 1 | 2009 | 104 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4055 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3625 | 0.020 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 2007 | 22 | 0.020 |
Why?
|
Feces | 1 | 2014 | 1511 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 878 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5890 | 0.020 |
Why?
|
Demography | 1 | 2010 | 1643 | 0.020 |
Why?
|
Risk Assessment | 1 | 2005 | 24330 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3671 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2007 | 1539 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5323 | 0.010 |
Why?
|
Species Specificity | 1 | 2007 | 2419 | 0.010 |
Why?
|
Anthropometry | 1 | 2007 | 1343 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4941 | 0.010 |
Why?
|
Vitamins | 1 | 2007 | 1638 | 0.010 |
Why?
|
Schools | 1 | 2007 | 1498 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18065 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2007 | 3442 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2007 | 12469 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 41800 | 0.010 |
Why?
|
Cognition | 1 | 2007 | 7080 | 0.010 |
Why?
|